Medically Speaking: Melanoma

Published Online: Wednesday, September 26, 2012
Follow Pharmacy_Times:
In this podcast, Susan Kesmodel, MD, of the University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore, discusses diagnosis, treatment, and prevention of melanoma.
 
To listen to this podcast, click here.
Related Articles
The FDA today approved a new indication for ramucirumab for the treatment of metastatic non-small cell lung cancer.
Merck’s anti–PD-1 therapy Keytruda has demonstrated an overall response rate of 18.5% among patients with PD-L1 positive, advanced triple-negative breast cancer, one of the most aggressive forms of breast cancer.
In healthy women, the cons of taking daily low-dose aspirin to prevent heart disease, cancer, and other serious illness outweigh the pros.
In a large, international study, pioglitazone (Actos) and rosiglitazone (Avandia) did not lead to an increased risk for bladder cancer, contradicting previous studies that suggested the opposite.
Latest Issues
$auto_registration$